Abstract
Cell fate decisions are controlled by complex signal transduction processes that transmit information via posttranslational protein modifications such as phosphorylation. In lymphoma, as in other cancer types, these signaling networks are often dysregulated and thus contribute to malignant transformation and tumor maintenance. For example, B-cell antigen receptor signals are rewired in certain lymphoma types, such as diffuse large B-cell lymphomas, to promote cell growth and survival of the malignant cell clones. Hence, global elucidation of such intricate signaling networks is important for an improved understanding of the biology of these tumors and the identification of target proteins for therapeutic purposes.
We describe here a mass spectrometry-based phosphoproteomic approach for characterization of intracellular signaling events and their dynamics. This integrated phosphoproteomic technology combines phosphopeptide enrichment and fractionation with liquid-chromatography-coupled mass spectrometry for the site-specific mapping and quantification of thousands of phosphorylation events in a given cell type. Such global signaling analyses provide valuable insights into oncogenic signaling networks and can inform drug development efforts.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Kurosaki T, Shinohara H, Baba Y (2010) B cell signaling and fate decision. Annu Rev Immunol 28:21–55. https://doi.org/10.1146/annurev.immunol.021908.132541
Shaffer AL 3rd, Young RM, Staudt LM (2012) Pathogenesis of human B cell lymphomas. Annu Rev Immunol 30:565–610. https://doi.org/10.1146/annurev-immunol-020711-075027
Duhren-von Minden M, Ubelhart R, Schneider D et al (2012) Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489(7415):309–312. https://doi.org/10.1038/nature11309
Davis RE, Ngo VN, Lenz G et al (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463(7277):88–92. https://doi.org/10.1038/nature08638
Young RM, Wu T, Schmitz R et al (2015) Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens. Proc Natl Acad Sci U S A 112(44):13447–13454. https://doi.org/10.1073/pnas.1514944112
Schmitz R, Wright GW, Huang DW et al (2018) Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med 378(15):1396–1407. https://doi.org/10.1056/NEJMoa1801445
Schmitz R, Young RM, Ceribelli M et al (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116–120. https://doi.org/10.1038/nature11378
Corso J, Pan KT, Walter R et al (2016) Elucidation of tonic and activated B-cell receptor signaling in Burkitt’s lymphoma provides insights into regulation of cell survival. Proc Natl Acad Sci U S A 113(20):5688–5693. https://doi.org/10.1073/pnas.1601053113
Young RM, Staudt LM (2013) Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov 12(3):229–243. https://doi.org/10.1038/nrd3937
Sacco F, Humphrey SJ, Cox J et al (2016) Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion. Nat Commun 7:13250. https://doi.org/10.1038/ncomms13250
Beausoleil SA, Jedrychowski M, Schwartz D et al (2004) Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A 101(33):12130–12135. https://doi.org/10.1073/pnas.0404720101
Singer D, Kuhlmann J, Muschket M et al (2010) Separation of multiphosphorylated peptide isomers by hydrophilic interaction chromatography on an aminopropyl phase. Anal Chem 82(15):6409–6414. https://doi.org/10.1021/ac100473k
Nilsson CL (2012) Advances in quantitative phosphoproteomics. Anal Chem 84(2):735–746. https://doi.org/10.1021/ac202877y
Bantscheff M, Lemeer S, Savitski MM et al (2012) Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal Bionanal Chem 404(4):939–965. https://doi.org/10.1007/s00216-012-6203-4
Junger MA, Aebersold R (2014) Mass spectrometry-driven phosphoproteomics: patterning the systems biology mosaic. Wiley Interdiscip Rev Dev Biol 3(1):83–112. https://doi.org/10.1002/wdev.121
Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26(12):1367–1372. https://doi.org/10.1038/nbt.1511
Cox J, Neuhauser N, Michalski A et al (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10(4):1794–1805. https://doi.org/10.1021/pr101065j
Tyanova S, Temu T, Sinitcyn P et al (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13(9):731–740. https://doi.org/10.1038/nmeth.3901
Ong S-E, Blagoev B, Kratchmarova I et al (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1(5):376–386. https://doi.org/10.1074/mcp.M200025-MCP200
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Häupl, B., Urlaub, H., Oellerich, T. (2019). Phosphoproteomic Analysis of Signaling Pathways in Lymphomas. In: Küppers, R. (eds) Lymphoma. Methods in Molecular Biology, vol 1956. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9151-8_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9151-8_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9150-1
Online ISBN: 978-1-4939-9151-8
eBook Packages: Springer Protocols